Page last updated: 2024-08-22

vasotocin and guanosine 5'-o-(3-thiotriphosphate)

vasotocin has been researched along with guanosine 5'-o-(3-thiotriphosphate) in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fahrenholz, F; Gimpl, G; Klein, U	1
Advenier, C; Bardou, M; Breuiller-Fouché, M; Cecchi, R; Croci, T; Descamps, L; Fradin, Y; Germain, G; Guagnini, F; Leroy, MJ; Marini, P; Pascal, M; Rouget, C; Viviani, N	1

Other Studies

2 other study(ies) available for vasotocin and guanosine 5'-o-(3-thiotriphosphate)

Article	Year
Alteration of the myometrial plasma membrane cholesterol content with beta-cyclodextrin modulates the binding affinity of the oxytocin receptor. Biochemistry, 1995, Oct-24, Volume: 34, Issue:42 Topics: Animals; beta-Cyclodextrins; Binding Sites; Cell Membrane; Cholesterol; Cholic Acids; Cyclodextrins; Detergents; Female; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Membrane Lipids; Molecular Structure; Myometrium; Oxytocin; Pregnancy; Receptors, Oxytocin; Solubility; Steroids; Vasotocin	1995
In vitro and in vivo pharmacological characterization of ethyl-4-[trans-4-[((2S)-2-hydroxy-3-[4-hydroxy-3[(methylsulfonyl)amino]-phenoxy]propyl) amino]cyclohexyl]benzoate hydrochloride (SAR150640), a new potent and selective human beta3-adrenoceptor agoni The Journal of pharmacology and experimental therapeutics, 2007, Volume: 321, Issue:3 Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Benzoates; Binding, Competitive; Cell Line; Cell Line, Tumor; Cells, Cultured; Cyclic AMP; Female; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Isoproterenol; Macaca fascicularis; Molecular Structure; Myometrium; Obstetric Labor, Premature; Oxytocin; Pregnancy; Propanolamines; Receptors, Adrenergic, beta-3; Sulfonamides; Tocolytic Agents; Transfection; Uterine Contraction; Vasotocin	2007

Article

Year

Alteration of the myometrial plasma membrane cholesterol content with beta-cyclodextrin modulates the binding affinity of the oxytocin receptor.

Biochemistry, 1995, Oct-24, Volume: 34, Issue:42

Topics: Animals; beta-Cyclodextrins; Binding Sites; Cell Membrane; Cholesterol; Cholic Acids; Cyclodextrins; Detergents; Female; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Membrane Lipids; Molecular Structure; Myometrium; Oxytocin; Pregnancy; Receptors, Oxytocin; Solubility; Steroids; Vasotocin

1995

In vitro and in vivo pharmacological characterization of ethyl-4-[trans-4-[((2S)-2-hydroxy-3-[4-hydroxy-3[(methylsulfonyl)amino]-phenoxy]propyl) amino]cyclohexyl]benzoate hydrochloride (SAR150640), a new potent and selective human beta3-adrenoceptor agoni

The Journal of pharmacology and experimental therapeutics, 2007, Volume: 321, Issue:3

Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Benzoates; Binding, Competitive; Cell Line; Cell Line, Tumor; Cells, Cultured; Cyclic AMP; Female; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Isoproterenol; Macaca fascicularis; Molecular Structure; Myometrium; Obstetric Labor, Premature; Oxytocin; Pregnancy; Propanolamines; Receptors, Adrenergic, beta-3; Sulfonamides; Tocolytic Agents; Transfection; Uterine Contraction; Vasotocin

2007